SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--diaDexus, Inc., today announced that the American Medical Association has issued a unique Category I Current Procedural Terminology (CPT®) code for the measurement of lipoprotein-associated phospholipase A2 (Lp-PLA2), a cardiovascular-specific inflammatory enzyme found in unstable, rupture-prone plaque. Plaque rupture is the leading cause of heart attack and stroke. diaDexus makes the PLAC test, the only Food and Drug Administration-approved blood test for the measurement of Lp-PLA2.
